slightly significantp = 0.051
In the study by Antonodimitrakis [ 24 ], stage IV emerged as a negative predictor factor at multivariate analysis for PFS ( p < 0.032), whereas the impact of metastatic disease was slightly significant at multivariate analysis for OS ( p = 0.051).